Ligand-mediated tertiary structure changes of reconstituted P-glycoprotein - A tryptophan fluorescence quenching analysis

被引:83
作者
Sonveaux, N
Vigano, C
Shapiro, AB
Ling, V
Ruysschaert, JM
机构
[1] Free Univ Brussels, Chim Phys Macromol Interfaces Lab, B-1050 Brussels, Belgium
[2] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada
关键词
D O I
10.1074/jbc.274.25.17649
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ligand-dependent changes in accessibility of purified P-glycoprotein, functionally reconstituted in liposomes, were investigated by fluorescence measurements.. Trp quenching experiments provided evidence that P-glyeoprotein adopts different tertiary structures upon binding of drug substrates in the absence and presence of MgATP and its nonhydrolyzable analog, MgATP gamma S, Five anthracycline derivatives were tested as drug substrates: daunorubicin, 4'-epi-doxorubicin, iododoxorubicin, 4-demethoxy-daunorubicin, and methoxy-morpholino-doxorubicin. Among them, daunorubicin and 4'-epi-doxorubicin have been shown to be rejected outside the multidrug-resistant cells, whereas the three others have been shown to accumulate in multidrug-resistant cells overexpressing P-glycoprotein and therefore retain their cytotoxic activity. A small conformational change was associated with nucleotide 'binding and amplified after nucleotide hydrolysis, Different conformational states were adopted by P-glycoprotein upon the addition of the anthracycline derivatives in the absence and presence of MgATP or MgATP gamma S. These conformational changes are shown to be related to the nature of the antitumor agents and more precisely to their capacity to accumulate in resistant cells, These data also suggest that the cytotoxicity of iododoxorubicin and 4-demethoxy-daunorubicin is related to the fact they are not transported by P-glycoprotein, On the contrary, methoxy-morpholino-doxorubicin cytotoxicity may be explained in terms of its rapid reincorporation into the:plasma membrane after being transported by P-glycoprotein.
引用
收藏
页码:17649 / 17654
页数:6
相关论文
共 35 条
[1]  
BOSCH L, 1996, BIOCHIM BIOPHYS ACTA, V1288, pF37
[2]   Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein [J].
Dey, S ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM ;
Ambudkar, SV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10594-10599
[3]  
DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291
[4]   THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE [J].
ENDICOTT, JA ;
LING, V .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :137-171
[5]   The role of passive transbilayer drug movement in multidrug resistance and its modulation [J].
Eytan, GD ;
Regev, R ;
Oren, G ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12897-12902
[6]   ASSOCIATION OF DAUNOMYCIN TO MEMBRANE DOMAINS STUDIED BY FLUORESCENCE RESONANCE ENERGY-TRANSFER [J].
FERRERMONTIEL, AV ;
GONZALEZROS, JM ;
FERRAGUT, JA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 937 (02) :379-386
[7]   P-glycoprotein - A mediator of multidrug resistance in tumour cells [J].
Germann, UA .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) :927-944
[8]   MDR1 gene expression in solid tumours [J].
Goldstein, LJ .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) :1039-1050
[9]  
GOTTESMAN MM, 1993, CANCER RES, V53, P747
[10]   ABC TRANSPORTERS - FROM MICROORGANISMS TO MAN [J].
HIGGINS, CF .
ANNUAL REVIEW OF CELL BIOLOGY, 1992, 8 :67-113